DNA methylation of Cldn5 was strongly linked to accelerated cognitive decline, even in individuals with low amyloid/tau burden, implying that vascular and barrier dysfunction may precede traditional AD pathology [82]. The gene discussed is MAPT; the disease is Alzheimer disease.